176 related articles for article (PubMed ID: 4101505)
1. Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses).
Cumings JN
Proc R Soc Med; 1971 Mar; 64(3):313-22. PubMed ID: 4101505
[No Abstract] [Full Text] [Related]
2. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
3. Introduction. Symposium on copper metabolism and Wilson's disease.
Goldstein NP; Owen CA
Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
[No Abstract] [Full Text] [Related]
4. [Biochemical study of Refsum's disease].
Sezille G; Biserte G
Pathol Biol (Paris); 1970 May; 18(9):551-8. PubMed ID: 4192793
[No Abstract] [Full Text] [Related]
5. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
6. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
Yeh SJ; Leu ML; Strickland GT
J Lab Clin Med; 1971 Mar; 77(3):438-44. PubMed ID: 5553728
[No Abstract] [Full Text] [Related]
7. Neurological diseases as reflections of general metabolic disturbances (Wilson's disease, Refsum's disease and metachromatic leukodystrophy).
Cumings JN
Int J Neurol; 1976; 11(1):28-37. PubMed ID: 65341
[No Abstract] [Full Text] [Related]
8. Similarity of chronic copper toxicity in rats to copper deposition of Wilson's disease.
Owen CA
Mayo Clin Proc; 1974 Jun; 49(6):368-75. PubMed ID: 4835807
[No Abstract] [Full Text] [Related]
9. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
Lange J
Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
[No Abstract] [Full Text] [Related]
10. [Current views on the pathogenesis of Wilson's disease].
Szeliga J
Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542
[No Abstract] [Full Text] [Related]
11. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
[No Abstract] [Full Text] [Related]
12. Phytanic acid in tissue lipids in Refsum's disease.
Skrbic TR; Cumings JN
Clin Chim Acta; 1969 Jan; 23(1):17-21. PubMed ID: 4178397
[No Abstract] [Full Text] [Related]
13. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
Prasad R; Kaur G; Walia BN
Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
[TBL] [Abstract][Full Text] [Related]
14. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
[No Abstract] [Full Text] [Related]
15. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Marecek Z; Heyrovský A; Volek V
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
[TBL] [Abstract][Full Text] [Related]
16. Wilson's disease. Clinical and laboratory maniestations in 40 patients.
Strickland GT; Leu ML
Medicine (Baltimore); 1975 Mar; 54(2):113-37. PubMed ID: 1117834
[No Abstract] [Full Text] [Related]
17. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
18. Refsum's disease: a disorder of lipid metabolism.
Rake M; Saunders M
J Neurol Neurosurg Psychiatry; 1966 Oct; 29(5):417-22. PubMed ID: 4162745
[No Abstract] [Full Text] [Related]
19. Diagnosis of Wilson's disease in children with liver disease. A report of two families.
Danks DM; Stevens BJ
Lancet; 1969 Jan; 1(7584):22-5. PubMed ID: 4178768
[No Abstract] [Full Text] [Related]
20. The existence of an alternative pathway for the degradation of branch-chained fatty acids, and its failure in heredopathia atactica polyneuritiformis (Refsum's disease).
Eldjarn L; Try K; Stokke O
Biochim Biophys Acta; 1966 Apr; 116(2):395-7. PubMed ID: 4163203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
